Mar 16, 2021 / 06:30PM GMT
Henry Capellan -
Okay. Good afternoon, everyone.
Christopher P. Lowe - Cortexyme, Inc. - COO, CFO & Treasurer
Good afternoon.
Henry Capellan -
Sorry about the delay. We have the management team of Cortexyme with us this afternoon. We're very pleased to have them with us. We have Casey Lynch, CEO; we have Chris Lowe, the CFO; and we have Mike Detke, the CMO, with us this afternoon. So thank you very much for joining us. Let's turn the call over to Chris Lowe.
Christopher P. Lowe - Cortexyme, Inc. - COO, CFO & Treasurer
Great. Good afternoon, everybody. I am Chris Lowe, Chief Operating Officer and Chief Financial Officer at Cortexyme. If you're new to Cortexyme, I think you will appreciate the elegance of our evidence to date.
Our proprietary library of small molecules target a pathogen, which we believe is upstream of other targets within many areas of CNS. We absolutely believe this is the game changer patients have been waiting for. I'm very excited to share our progress
Cortexyme Inc at Oppenheimer Healthcare Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
